KLC
LUNG icon

Kent Lake Capital’s Pulmonx LUNG Stock Holding History

Kent Lake Capital’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$2.08M Buy
+328,291
New +$2.52M 0.94% 31

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Kent Lake Capital's LUNG Position: Q2 2024 in Review

Kent Lake Capital opened a new position in Pulmonx (LUNG) in Q2 2024: 328,291 shares worth $2.08M. The stake represents 0.94% of the portfolio and ranks #31 among its holdings.

112 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

  • Kent Lake Capital held 328,291 shares of Pulmonx worth $2.08M as of Q2 2024.
  • Pulmonx was a new Kent Lake Capital position in Q2 2024.
  • Pulmonx made up 0.94% of Kent Lake Capital's portfolio in Q2 2024, its #31 holding.
  • 112 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on Kent Lake Capital's 13F filing for Q2 2024, filed 14 Aug 2024.